Adeno-Associated Virus (AAV) Packaging Services Market Growth To $2.52 Billion Creates New Opportunities Across The Industry
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Adeno-Associated Virus (AAV) Packaging Services Market Revenue Growth On Track For A 11.3% CAGR Through 2030
The adeno-associated virus (AAV) packaging services market size has witnessed rapid expansion in recent years. This market is anticipated to expand from $1.48 billion in 2025 to $1.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.1%. The historic period’s growth can be attributed to several factors, including an increase in gene therapy research activities, greater funding directed towards rare disease research, the expansion of preclinical and clinical trial pipelines, the emergence of more biotechnology startups, and advancements in viral vector production technologies.
The adeno-associated virus (AAV) packaging services market is projected to experience swift expansion in the coming years. It will grow to $2.52 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. This anticipated growth during the forecast period is primarily fueled by a rise in gene therapy approvals, increasing demand for commercial-scale GMP manufacturing, greater investments in precision medicine, the broadening of cell and gene therapy pipelines, and a surge in strategic collaborations between biotechnology companies and CDMOs. Furthermore, significant trends expected over this period include a heightened demand for high-titer and high-purity AAV production, the expanded availability of GMP-compliant clinical-grade AAV packaging, an intensifying focus on scalable large-scale manufacturing solutions, the increasing use of advanced analytical and release testing services, and the growing practice of outsourcing AAV vector manufacturing to CDMOs.
Get A Free Sample Report With In-Depth Market Insights:
Adeno-Associated Virus (AAV) Packaging Services Market Growth Factors Behind Sustained Expansion
The increasing need for gene therapy development is anticipated to drive the expansion of the adeno-associated virus (AAV) packaging services market in the future. Gene therapy development involves the creation of treatments designed to alter or substitute defective genes for disease management. The demand for gene therapy development is escalating due to the increasing occurrence of genetic and rare diseases, thereby heightening the necessity for sophisticated treatments that address the fundamental genetic origins of these ailments. Adeno-associated virus (AAV) packaging services facilitate gene therapy development by offering expert viral vector production and purification, ensuring a scalable and premium AAV supply for both clinical investigations and therapeutic applications. For example, data from July 2023, provided by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership body, showed that 247 gene therapies were in Phase II at the close of the first quarter of 2023. This figure subsequently grew by 5%, reaching 260 by the conclusion of the second quarter. Consequently, the growing requirement for gene therapy development is fueling the expansion of the adeno-associated virus (AAV) packaging services market.
Adeno-Associated Virus (AAV) Packaging Services Market Segment Analysis: What Are The Core Market Categories?
The adeno-associated virus (AAV) packaging services market covered in this report is segmented –
1) By Service Type: Research-Grade Adeno-Associated Virus (AAV) Packaging (RUO), Good Manufacturing Practice (GMP) Clinical Adeno-Associated Virus (AAV) Packaging, Good Manufacturing Practice (GMP) Late-Stage And Commercial Supply, Analytical And Release Testing, Process Development And Tech Transfer
2) By Vector Type: Adeno-Associated Virus (AAV) 2, Adeno-Associated Virus (AAV) 5, Adeno-Associated Virus (AAV) 8, Adeno-Associated Virus (AAV) 9
3) By Scale Of Production: Small-Scale Production, Mid-Scale Production, Large-Scale Production
4) By Therapeutic Application: Ophthalmology, Neuromuscular And Central Nervous System, Metabolic Or Rare Genetic Disorders, Oncology, Cardiovascular, Other Indications
5) By End User: Biotechnology And Biopharmaceutical Companies, Academic And Research Institutes, Contract Research Organizations, Contract Manufacturing Organizations, Healthcare And Diagnostic Laboratories
Subsegments:
1) By Research-Grade Adeno-Associated Virus (AAV) Packaging (RUO): Small Scale Production, Pilot Scale Production, Custom Vector Design, Preclinical Study Supply
2) By GMP Clinical Adeno-Associated Virus (AAV) Packaging: Phase One Clinical Supply, Phase Two Clinical Supply, Phase Three Clinical Supply, Patient Specific Batch Production
3) By GMP Late-Stage And Commercial Supply: Commercial Batch Production, Technology Transfer Support, Large Scale Manufacturing, Regulatory Submission Support
4) By Analytical And Release Testing: Potency Testing, Purity Testing, Identity Testing, Safety Testing, Stability Testing
5) By Process Development And Tech Transfer: Upstream Process Development, Downstream Process Development, Scale-Up Process Optimization, Technology Transfer To Manufacturing, Process Characterization
Adeno-Associated Virus (AAV) Packaging Services Market Industry Trends Fueling Future Revenue Growth
Major companies in the adeno-associated virus (AAV) packaging services market are prioritizing the development of innovative solutions, including on-demand AAV viral vector packaging platforms, to improve flexibility, accelerate research schedules, and ensure consistent, high-quality viral vector manufacturing. On-demand AAV viral vector packaging platforms are services designed to provide custom AAV production in specific serotypes with integrated quality controls, helping researchers conserve time and obtain reliable, high-titer vectors for gene delivery applications. As an illustration, in January 2025, Addgene Inc., a US-based nonprofit scientific organization, launched its “Packaged on Request” AAV packaging service. This service allows scientists to select from over 3,000 AAV plasmids within Addgene’s repository and request packaging in serotypes such as AAV1, AAV2, AAV5, AAV8, and AAV Retrograde capsids. Each preparation undergoes extensive quality control procedures, including ddPCR titering, purity testing, sterility testing, and viral genome sequencing, guaranteeing research-grade standards comparable to their in-stock viral preparations. The service also simplifies legal approvals and technology transfer processes, thus reducing administrative burdens while maintaining high titers suitable for various in vivo and in vitro uses.
Adeno-Associated Virus (AAV) Packaging Services Market Top Companies Driving Competitive Growth
Major companies operating in the adeno-associated virus (AAV) packaging services market are Thermo Fisher Scientific Inc., AGC Biologics Inc., Lonza Group AG, Charles River Laboratories International Inc., Resilience Biotechnologies Inc., GenScript Biotech Corporation, Takara Bio Inc., OxB CDMO Inc., 3PBIOVIAN, VectorBuilder, Genezen Labs, Addgene Inc., PackGene Biotech Inc., Porton Advanced Solutions Ltd., Creative Biogene, Yposkesi SAS, AAVnerGene Inc., Virovek Inc., WuXi Advanced Therapies Co. Ltd., BioInnovatise Inc.
View The Full Adeno-Associated Virus (AAV) Packaging Services Market Report:
Adeno-Associated Virus (AAV) Packaging Services Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the adeno-associated virus (AAV) packaging services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adeno-associated virus (AAV) packaging services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
